142 related articles for article (PubMed ID: 38019228)
1. A Polyherbal Ashwagandha Formulation Exhibits Adjunctive Antitumor Efficacy Against U266 Myeloma Cells by Multi-Strategic Cytotoxic Effects: An Experimental Approach.
Kapoor S; Gupta N; Sharma A
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3705-3714. PubMed ID: 38019228
[TBL] [Abstract][Full Text] [Related]
2. Habb-e-Asgandh Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Multiple Myeloma Cells (RPMI8226).
Vashist A; Gupta N; Nafees S; Sharma A
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3629-3639. PubMed ID: 36444574
[TBL] [Abstract][Full Text] [Related]
3. Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules.
Kumar R; Gupta N; Himani ; Sharma A
Mol Biol Rep; 2018 Dec; 45(6):2429-2439. PubMed ID: 30311125
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma.
Ma J; Wang S; Zhao M; Deng XS; Lee CK; Yu XD; Liu B
BMC Cancer; 2011 Jun; 11():255. PubMed ID: 21679466
[TBL] [Abstract][Full Text] [Related]
5. A Polyherbal Formulation Habb-e-Ustukhuddus Induces Apoptosis and Inhibits Cell Migration in Lung and Breast Cancer Cells without Any Toxicity in Mice.
Punia R; Ali M; Shamsi Y; Singh RP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2713-2727. PubMed ID: 37642058
[TBL] [Abstract][Full Text] [Related]
6. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
Wang WQ; Zhao XY; Wang HY; Liang Y
J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
Song Y; Hou J; Kang L; Gao S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells.
Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Koh W; Jung JH; Kim SH; Sung-Hoon K
BMC Cancer; 2012 Jan; 12():28. PubMed ID: 22260501
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.
Ocio EM; Vilanova D; Atadja P; Maiso P; Crusoe E; Fernández-Lázaro D; Garayoa M; San-Segundo L; Hernández-Iglesias T; de Alava E; Shao W; Yao YM; Pandiella A; San-Miguel JF
Haematologica; 2010 May; 95(5):794-803. PubMed ID: 19951978
[TBL] [Abstract][Full Text] [Related]
10.
Terzi H; Altun A; Şencan M
Indian J Med Res; 2019 Dec; 150(6):630-634. PubMed ID: 32048627
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
Wang X; Walter M; Urak R; Weng L; Huynh C; Lim L; Wong CW; Chang WC; Thomas SH; Sanchez JF; Yang L; Brown CE; Pichiorri F; Htut M; Krishnan AY; Forman SJ
Clin Cancer Res; 2018 Jan; 24(1):106-119. PubMed ID: 29061640
[No Abstract] [Full Text] [Related]
13. Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one.
Shirato K; Imaizumi K; Miyazawa K; Takasaki A; Mizuguchi J; Che XF; Akiyama S; Tomoda A
Biol Pharm Bull; 2008 Jan; 31(1):62-7. PubMed ID: 18175943
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
Que W; Chen J; Chuang M; Jiang D
APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
[TBL] [Abstract][Full Text] [Related]
15. Development of standard operating procedure and standardization of Habb-e-Banafsha Qawi-A Unani polyherbal formulation.
Ali A; Sumbul S; Ahmad MM; Ahmad S; Kabir H; Abdin MZ
J Pharm Bioallied Sci; 2015; 7(4):250-3. PubMed ID: 26681876
[TBL] [Abstract][Full Text] [Related]
16. Habb-e-Asgand, polyherbal Unani formulation, protects liver and antioxidative enzymes against paracetamol induced hepatotoxicity.
Ali M; Khan SA; Chang PS; Haque R; Bhatia K; Ahmad S
Pharm Biol; 2014 Jan; ():. PubMed ID: 24392788
[TBL] [Abstract][Full Text] [Related]
17. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells.
Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH
J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use.
Wu Z; Wu L; Zou L; Wang M; Liu X
J Chemother; 2023 Apr; 35(2):131-141. PubMed ID: 35427214
[TBL] [Abstract][Full Text] [Related]
19. Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients.
de Oliveira MB; Fook-Alves VL; Eugenio AIP; Fernando RC; Sanson LFG; de Carvalho MF; Braga WMT; Davies FE; Colleoni GWB
Cancer Lett; 2017 Sep; 403():206-215. PubMed ID: 28645562
[TBL] [Abstract][Full Text] [Related]
20. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
Wang Y; Zhang XL; Sun CM
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]